Literature DB >> 33991634

Ni and Cr impurities profile in Valeriana officinalis L., radix-based herbal medicinal product available in polish pharmacies due to ICH Q3D guideline.

Kamil Jurowski1, Maria Fołta2, Barbara Tatar2, Mehmet Berkoz3, Mirosław Krośniak2.   

Abstract

Elemental impurities (EIs) profiling in final pharmaceutical products is often not adequately treated, however it is crucial problem in pharmaceutical analysis by reason of the various regulatory authorities (like ICH Q3D guideline). EIs in pharmaceuticals may arise from numerous sources of which the herbal ingredients are not a frequent subject of pharmaceutical analyses. However, based on number of traditional use registrations per year for herbal medicinal products (HMPs) in the EU, it can be stated that monocomponent HMPs are still very popular for use. Due to the high frequency of use, exposure to EIs from HMPs may be high during long-term use. The aim of our article was Ni and Cr impurities profiling of Valeriana officinalis L., radix (Valerian root) as an example of the HMP available in Polish pharmacies for the relief of mild nervous tension and sleep disorders. The choice of metals was justified by: (1) a single dose of Ni administered via oral route can induce dermatitis in nickel-sensitised individuals; (2) Cr is a very problematic element from toxicological point of view. Our results indicate that the standards of the ICH Q3D guideline are met for all EIs.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chromium; Metal impurities profiling; Nickel; Pharmaceutical analysis

Mesh:

Substances:

Year:  2021        PMID: 33991634     DOI: 10.1016/j.yrtph.2021.104945

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  6 in total

1.  The Toxicological Assessment of Content and Exposure of Heavy Metals (Pb and Cd) in Traditional Herbal Medicinal Products with Marshmallow Root (Althaea officinalis L., radix) from Polish Pharmacies.

Authors:  Kamil Jurowski; Mirosław Krośniak
Journal:  Toxics       Date:  2022-04-13

2.  The Level of Cadmium Impurities in Traditional Herbal Medicinal Products with Plantago lanceolata L., folium (Ribwort Plantain Leaves) Available in Polish Pharmacies - Comprehensive Toxicological Risk Assessment Including Regulatory Point of View and ICH Q3D Elemental Impurities Guideline.

Authors:  Kamil Jurowski; Maria Fołta; Barbara Tatar; Mirosław Krośniak
Journal:  Biol Trace Elem Res       Date:  2021-08-10       Impact factor: 4.081

3.  The Comprehensive Toxicological Assessment of Total Chromium Impurities in Traditional Herbal Medicinal Product with Thymi herba (Thymus vulgaris L. and Thymus zygis L.) Available in Pharmacies in Poland: Short Communication.

Authors:  Kamil Jurowski; Maria Fołta; Barbara Tatar; Mirosław Krośniak
Journal:  Biol Trace Elem Res       Date:  2021-08-10       Impact factor: 4.081

4.  The Toxicological Risk Assessment of Cu, Mn, and Zn as Essential Elemental Impurities in Herbal Medicinal Products with Valerian Root (Valeriana officinalis L., radix) Available in Polish Pharmacies.

Authors:  Kamil Jurowski; Maria Fołta; Barbara Tatar; Mehmet Berkoz; Mirosław Krośniak
Journal:  Biol Trace Elem Res       Date:  2021-06-09       Impact factor: 3.738

5.  The Toxicological Risk Assessment of Dermal Exposure of Patients Exposed to Nickel and Chromium due to Application of Ointments with Marjoram Herb Extract (Majoranae Herbae Extractum) Available in Polish Pharmacies.

Authors:  Kamil Jurowski; Maria Fołta; Barbara Tatar; Mehmet Berkoz; Mirosław Krośniak
Journal:  Biol Trace Elem Res       Date:  2021-06-30       Impact factor: 3.738

6.  The Health Risk Assessment of Essential Elemental Impurities (Cu, Mn and Zn) Through the Dermal Exposure of Herbal Ointment Extracted from Marjoram Herb (Majoranae herbae extractum).

Authors:  Kamil Jurowski; Maria Fołta; Barbara Tatar; Mehmet Berkoz; Mirosław Krośniak
Journal:  Biol Trace Elem Res       Date:  2021-07-31       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.